1. Assessing Administration and Billing of Vedolizumab and Infliximab Across IBD Sites of Care: 720. (October 2016) Authors: Null, Kyle D.; Cameron, Ann; Kumar, Varun M.; Lissoos, Trevor; Luo, Michelle Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model. Issue 2 (18th January 2018) Authors: Scott, Frank I; Shah, Yash; Lasch, Karen; Luo, Michelle; Lewis, James D Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 2(2018) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model. Issue 2 (18th January 2018) Authors: Scott, Frank I; Shah, Yash; Lasch, Karen; Luo, Michelle; Lewis, James D Journal: Inflammatory bowel diseases Issue: Volume 24:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in Patient-Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD): Results From the IBD Partners Patient Powered Research Network. Issue 2 (23rd September 2019) Authors: Long, Millie D; Martin, Christopher F; Chen, Wenli; Luo, Michelle Journal: Crohn's & colitis 360 Issue: Volume 1:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Changes in Patient‐Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD): 624. (October 2017) Authors: Long, Millie D.; Martin, Christopher; Chen, Wenli; Jaeger, Elizabeth; Barocas, Morris; Luo, Michelle Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (18th October 2019) Authors: Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Hua... Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (3rd May 2019) Authors: Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Hua... Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 11(2019) Page Start: 1854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Correction: Vedolizumab for Ulcerative Colitis. (April 2019) Authors: Narula, Neeraj; Peerani, Farhad; Meserve, Joseph; Kochhar, Gursimran; Chaudrey, Khadija; Hartke, Justin; Chilukuri, Prianka; Koliani-Pace, Jenna; Winters, Adam; Katta, Leah; Shmidt, Eugenia; Hirten, Robert; Faleck, David; Parikh, Malav P.; Whitehead, Diana; Boland, Brigid S.; Singh, Siddharth; Sa... Journal: American journal of gastroenterology Issue: Volume 114:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome. (January 2019) Authors: Lacy, Brian; Ayyagari, Rajeev; Guerin, Annie; Lopez, Andrea; Shi, Sherry; Luo, Michelle Journal: Therapeutic advances in gastroenterology Issue: Volume 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis. (4th January 2020) Authors: Scott, Frank I; Luo, Michelle; Shah, Yash; Lasch, Karen; Vajravelu, Ravy K; Mamtani, Ronac; Fennimore, Blair; Gerich, Mark E; Lewis, James D Journal: Journal of Crohn's and colitis Issue: Volume 14:Number 5(2020) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗